M&A Deal Summary

Jubilant Pharmova Acquires Triad Isotopes - Radiopharmacy Business

On May 5, 2017, Jubilant Pharmova acquired life science company Triad Isotopes - Radiopharmacy Business from Triad Isotopes

Acquisition Highlights
  • This is Jubilant Pharmova’s 3rd transaction in the Life Science sector.
  • This is Jubilant Pharmova’s 2nd transaction in the United States.

M&A Deal Summary

Date 2017-05-05
Target Triad Isotopes - Radiopharmacy Business
Sector Life Science
Buyer(s) Jubilant Pharmova
Sellers(s) Triad Isotopes
Deal Type Divestiture

Target

Triad Isotopes - Radiopharmacy Business

United States
Triad Isotopes, Inc. - Radiopharmacy Business is the second largest radiopharmacy network in the US with more than 50 pharmacies, distributing nuclear medicine products to the largest National GPOs, regional health systems, stand-alone imaging centres, cardiologists and hospitals.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Jubilant Pharmova

Noida, India

Category Company
Founded 1978
Sector Life Science
Employees5,547
Revenue 71.9B INR (2025)
DESCRIPTION

Jubilant Pharmova is a manufacturing and research outsourcing service for the global pharmaceutical industry. Jubilant Pharmova was founded in 1978 and is based in Noida, Uttar Pradesh.


DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 3 of 3
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 2 of 2
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-11-15 Pace Marketing Specialities

Ghaziabad, India

Pace Marketing Specialities Ltd. provides manufacturing services for adhesives of consumer products.

Buy -

Seller(S) 1

SELLER

Triad Isotopes

Orlando, Florida, United States

Category Company
Founded 2006
Sector Life Science
DESCRIPTION

Triad Isotopes, Inc. is an independent nuclear pharmacy in the US that compounds and distributes radiopharmaceuticals used for both diagnostic imaging procedures and for treatment of certain diseases.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-11-08 Pee Dee Isotopes

Myrtle Beach, South Carolina, United States

Pee Dee Isotopes, Inc. is a radiopharmaceutical company.

Buy -